- Category: Search for a Cure
- Published on Wednesday, 01 August 2012 00:00
- Written by Gregory Fowler
A cure for HIV was among the key themes at the XIX International AIDS Conference (AIDS 2012) last week in Washington, DC. While researchers are pursing several approaches and have seen some encouraging results, they cautioned that a cure is not yet around the corner.
[Steven Deeks, IAS Towards a Cure press conference]
In the lead-up to the conference, the International AIDS Society (IAS) launched its first strategy for advocacy and research towards a cure for HIV, developed over the past 2 years by an international working group of experts in the field.
Investigators presented a selection of the latest cure research at an oral session and press conference, including use of the cancer drug vorinostat to purge latent HIV in resting cells, news of 2 bone marrow transplant recipients who have undetectable HIV after receiving mild chemotherapy that allowed them to stay on antiretroviral drugs, and a cohort of French patients who are controlling HIV after starting treatment during the acute stage of infection.
"Today might be considered the day when the cure research agenda moves form the basic science lab into the clinic," said Steven Deeks from UCSF, co-chair (with Francois Barre-Sinoussi) of the IAS working group. But he cautioned that a widely applicable functional cure is a long-term goal that probably will not be attained for at least a decade.